Weight-loss stock surge after Novo Nordisk's study reveals heart benefits of obesity drug Wegovy. 20% reduced risk in heart events, shares rise.
from World News, Latest World News, Breaking News and Headlines Today | Hindustan Times https://ift.tt/cIo5FW9
via IFTTT
from World News, Latest World News, Breaking News and Headlines Today | Hindustan Times https://ift.tt/cIo5FW9
via IFTTT